Introduction
Neuregulins are ligands for ErbB receptor tyrosine kinases (Holmes et al., 1992; Wen et al., 1992; Marchionni et al., 1993; Ho et al., 1995) . More than 15 distinct neuregulin isoforms have been identi®ed. These isoforms are generated from the neuregulin-1 (NRG-1) gene by alternate splicing of nascent NRG-1 transcripts, or by initiation of NRG-1 gene transcription at dierent sites (Peles and Yarden, 1993) . NRG-1/ErbB signalling plays an essential role in a variety of biological processes, such as cell growth, differentiation, morphogenesis, survival, and apoptosis (Gassmann et al., 1995; Lee et al., 1995; Meyer and Birchmeier, 1995; Grimm and Leder, 1997; Chausovsky et al., 1998; Liu et al., 1998a,b) .
A novel cDNA, termed, g-heregulin, putatively derived from the NRG-1 gene, was isolated from the human breast cancer cell line, MDA-MB-175, and was identi®ed as an autocrine growth factor for these cells (Schaefer et al., 1997) . g-Heregulin possesses two distinct regions: an N-terminal domain that is distinct from those of all other NRG-1 isoforms and that includes a hydrophobic sequence, and a C-terminal NRG-1 extracellular domain that is identical to other NRG-1 isoforms. This latter domain includes an immunoglobulin (Ig)-like domain, a glycosylated segment and an EGF-like domain ( Figure 1a ). The gheregulin EGF-like domain, as in other NRG-1 isoforms, is likely involved in receptor binding and activation. g-Heregulin was shown to stimulate growth of MDA-MB-175 cells, which also express ErbB receptors (Schaefer et al., 1997) . That g-heregulin is a normal NRG isoform was suggested by Southern blot analysis using a cDNA probe encoding either the unique N-terminal region, or the common C-terminal NRG region. These studies suggested a similar pattern of hybridization by the two probes when tested with DNA prepared from either MDA-MB-175 or MDA-MB-231 cells. The g-heregulin transcript, detected by Northern blot analysis using a cDNA probe encoding the unique g-heregulin N-terminal sequence, is widely distributed in mesenchymal and neuronal tissues, including testis, ovary, and skeletal muscle. The transcript was also identi®ed, although at lower abundance in heart, brain, kidney, thymus and prostate (Schaefer et al., 1997) . However, in these studies (Schaefer et al., 1997) Northern blot analysis was not performed with the C-terminal NRG-1-speci®c probe.
In an eort to examine g-heregulin expression in mouse development, by use of RT ± PCR, we were unable to detect g-heregulin expression in either normal mouse embryos at dierent stages of development or in various normal adult mouse tissues. However, in these studies PCR products were observed with primers speci®c for either the unique N-terminal domain or the C-terminal NRG-1 domain. Here we show that in MDA-MB-175 cells g-heregulin is the product of a DOC-4/NRG-1 fusion gene resulting from a chromosome 8:11 translocation.
Results and discussion
g-Heregulin is expressed only in MDA-MB-175 cells and not in normal tissues
To clone the mouse homologue of g-heregulin and to study its expression during mouse embryo development, RT ± PCR was performed using total RNA isolated from E11.5 mouse embryos, and a set of degenerate primers (g-5 and g-3) corresponding to the unique N-terminal sequence of g-heregulin (Table 1) . A 1153 bp mouse cDNA fragment was obtained and con®rmed as g-heregulin by sequence analysis. To examine the expression of g-heregulin, three nested sets of primers (Table 1) were designed to allow amplification of cDNA encoding the unique g-heregulin Nterminal domain, the NRG-1-speci®c C-terminal domain, or both ( Figure 1a ). As shown in Figure 1b , both an 1132 bp PCR product corresponding to the unique g-heregulin N-terminal region and an 165 bp product corresponding to the NRG-1 EGF-like domain were detected using RNA prepared from E9.5 to E13.5 mouse embryos or MDA-MB-175 cells. Although an 1044 bp PCR product corresponding to the region spanning both the N-and C-terminal regions was detected with RNA isolated from the MDA-MB-175 cells, no product was obtained with RNA from mouse embryonic tissues (Figure 1b) . Since the expected PCR products were obtained with mouse embryo RNA and the g-heregulin-and NRG-1-speci®c primers, failure to detect a product with the spanningregion primers is not due to a problem with embryo RNA preparation.
Expression of g-heregulin in adult tissues and other breast cancer cells was also examined by RT ± PCR using the spanning-region primers. g-Heregulin expression was also not observed in either MCF-7 or MDA-MB-453 breast cancer cells, or in adult mouse brain and heart ( Figure 1c ). SK-BR3 and T-47D breast cancer cells were also examined and no g-heregulin expression was detected (data not shown). In all of the above experiments, RNA treated without reverse transcription was used as a negative control for RT ± PCR (data not shown) and b-actin transcripts were examined by RT ± PCR with primers encoding the identical sequences of human and mouse b-actin genes as a control for the integrity of the RNA/cDNA used in the experiment (Figure 1c ). Moreover, all PCR products obtained were cloned and con®rmed to encode the expect product, by sequencing analysis.
g-Heregulin N-terminal sequence is localized at 11q13, whereas the C-terminal sequence is localized at 8p12
Since our RT ± PCR data indicated that g-heregulin is only expressed in MDA-MB-175 cells, we questioned if g-heregulin is the product of a fusion gene in this breast cancer cell line. To this end, in situ hybridization was performed with two distinct probes. The ®rst probe (1132 bp) corresponded to the unique N-terminal sequence of g-heregulin (nucleotides 1 ± 1132 of the coding sequence) (Schaefer et al., 1997) , and the second probe (900 bp) encoded the extracellular domain of a membrane-anchored NRG-1 isoform (NDF-a2c) (nucleotides 1 ± 900 of the coding sequence) (Wen et al., 1994) , in which 851 bp (50 ± 900) were identical to the Cterminal region of g-heregulin. Fluorescence in situ hybridization results are shown in Figure 2 . With the N-terminal probe, all 20 metaphase spreads from a normal human male showed a signal on chromosome 11 in the region 11q13 ± 11q14, with 83% of this signal in the distal portion of band 11q13 (Figure 2a) . A total of 12 non-speci®c background dots were observed in these 20 metaphase spreads. A similar result was obtained from hybridization of the probe to 15 spreads from another normal male (data not shown). However, for the NRG-1 extracellular domain probe, in which 20 spreads were examined from the ®rst normal male, all spreads showed signals on one or both chromatids of chromo- Table 1 Primers used in RT ± PCR, cloning and sequencing experiments g-5 g-3 p1 p4 p3 p6 p2 p5
5'-GCC ATG GAC(T) GTG(ACT) AAG(A) GAG(A)-3' 5'-T(C)TC G(A)TA CAT T(C)TG T(C)CC T(C)TC CAT-3'
5'-ATG GAC GTG AAG GAG AGG AAG-3' 5'-GGC TGC AGG TGC CAG TTT AGG-3' 5'-GAG AAG GAG AAA ACT TTC-3' 5'-CAG AAA GGG AGT GGA CGT ACT-3' 5'CCT AAA CTG GCA CCT GCA GCC-3' 5'-GAA AGT TTT CTC CTT GTC-3' Figure 1 Examination of g-heregulin expression. (a) A schematic structure of g-heregulin. Arrows indicate the location of primers (p1 ± p6) used for RT ± PCR, and the major motifs are indicated as N-terminal, the unique N-terminal region; TM, the hydrophobic transmembrane segment; Ig-L, an immunoglobulin-like domain; Spacer, a glycosylated intervening segment; and EGF-L, and EGF-like domain. (b) g-Heregulin expression was examined by RT ± PCR with primers p1 ± p4 for the N-terminal region, p3 ± p6 for the C-terminal EGF-like domain and p2 ± p5 for both domains. As detailed in Materials and methods, RNA samples were isolated from whole embryos at dierent developmental stages (E9.5, E10.5 or 13.5). (c) RT ± PCR was similarly performed with total RNA puri®ed from adult mouse brain and heart tissues, and the human breast cancer cell lines, MDA-MB-175 (175), MCF-7 and MDA-MB-453 (453). b-actin transcripts were examined with RT ± PCR as a control for the integrity of the RNA/cDNA used in this experiment g-Heregulin is a fusion gene product X Liu et al some 8 in the region 8p11.1 ± 8p21; 60% of this signal was at 8p12 (Figure 2b) . A total of 16 non-speci®c background dots were observed in these 20 spreads. A similar result was obtained from hybridization of the probe to ten spreads from another normal male (data not shown). These results suggest that g-heregulin is the product of two genes fused as a result of a chromosomal translocation. The unique N-terminal portion is from a gene localized to 11q13 and the C-terminal portion is from the NRG-1 gene at 8p12.
g-Heregulin is derived from a chromosome translocation dic(8:11) in MDA-MB-175 cells
To con®rm the potential chromosome 8:11 translocation, chromosome painting was performed on MDA- Figure 2c . The majority of metaphase spreads showed two or three normal-sized #8 chromosomes, two normal-sized #11 chromosomes, and three long fusion chromosomes consisting of a portion of chromosome 11 from 11pter ± 11q13 joined to an acentric segment of chromosome 8. Variant cells showed dierent numbers of each of these three chromosomes (#8, #11 or the fusion chromosome). However, at least two fusion chromosomes were present in each metaphase spread. Furthermore, cohybridization to the cells of the paint speci®c for chromosome 8 and the centromeric probe for chromosome 11 was observed, as shown in Figure  2d . This, plus the DAPI banding pattern, con®rmed the orientation of chromosome 11 in the fusion chromosome. To precisely characterize the fusion portion from chromosome 8, PRINS was performed with a primer for the centromere of chromosome 8, as shown in Figure 2e . This revealed an inactive #8 centromere immediately distal to the junction of chromosome 11 and chromosome 8 in the fusion chromosome. Thus, this result supports a breakpoint on chromosome 8 at 8p12. A summary diagram of the formation of the fusion chromosome, described as: dic(8:11)(8qter?8p12::11q13?11pter), is shown in Figure 2f . Recently, a stress-induced gene downstream of CHOP, termed DOC-4, was identi®ed (Wang et al., 1998) . DOC-4 encodes a 2825 amino acid transmembrane protein. Its N-terminal region, including a hydrophobic transmembrane segment, is identical to that of g-heregulin. By contrast with membraneanchored NRG-1 isoforms, which are type-I transmembrane proteins (N-terminus located extracellularly and C-terminus, intracellularly), the DOC-4 protein is a type-II transmembrane protein. If the hydrophobic segment of DOC-4 domain also acts as a transmembrane domain for g-heregulin, and given that the EGF-like ligand-containing domain of g-heregulin is secreted (Schaefer et al., 1997) , then unlike other membrane-anchored NRG-1 isoforms, g-heregulin must be a type-II membrane protein and release of the EGF-like domain must involve proteolytic processing of its C-terminal region, rather than the N-terminal region observed with other NRG-1 isoforms (Liu et al., 1998a,b) .
MB-175 cells, as shown in
In summary, we have provided molecular and cytogenetic evidence that g-heregulin is not a native NRG-1 gene isoform, but is the product of a DOC-4/ NRG-1 fusion gene resulting from a chromosome 8:11 translocation. This conclusion is supported by examination of the DOC-4 and NRG-1 amino acid sequences (Figure 3) . Presumably, the translocation forms a new intron, which leads to splicing between DOC-4 donor and NRG-1 acceptor sequences resulting in the g-heregulin transcript. This is the ®rst demonstration that malignant transformation is associated with a translocation that gives rise to a mutated NRG-1 gene. This results in the expression of an autocrine factor, g-heregulin, under the control of the DOC-4 promoter, which may participate in proliferation of breast cancer cells. Whether this growth factor is also involved in the pathophysiology of other solid tumours, and thus is potentially a target for novel anti-cancer therapies, is currently under investigation.
Materials and methods

Cloning of the N-terminal region of g-heregulin mouse homologue
Total RNA was isolated from whole E11.5 mouse embryos using an RNA puri®cation Kit (Gibco ± BRL). Using an RT ± PCR Kit (Gibco ± BRL), single strand cDNAs were obtained by reverse transcription with oligo-dT 12 ± 18 . PCR was then performed according to the manufacturer's instructions with a set of degenerate primers (g-5 and g-3) corresponding to the unique N-terminal sequence of g-heregulin (Table 1) . The PCR products were cloned into a TA cloning vector (Stratagene) and sequenced.
Detection of g-heregulin expression in normal tissues by RT ± PCR Total RNA was isolated from mouse embryos at dierent developmental stages (from E9.5 ± 13.5), from adult mouse heart and brain, and from the breast cancer cell lines, MDA-MB-175, MCF-7 and MDA-MB-453. To examine g-heregulin expression during development, three sets of primers were designed based on identical sequences in the mouse and human genes ( Table 1 ). The ®rst set of primers ampli®ed cDNA encoding the unique N-terminal domain, the second ampli®ed cDNA encoding the EGF-like domain, and the third ampli®ed cDNA spanning both domains. The primers used in a control RT ± PCR for the integrity of the cDNA are 5'-GTC GTC GAC AAC GGC TCC GGC ATG, and 5'-TGT CAA ACA TGA TCT GGG TCA TC, which encode identical sequences of human and mouse b-actin genes. All PCR products were cloned and veri®ed by sequencing.
Fluorescence in situ hybridization (FISH)
To prepare probes for detecting single copy genes, cDNAs were labelled by nick translation with biotin 14-dATP. One probe encoded the unique N-terminal sequence of g-heregulin (nucleotides 1 ± 1122 of the coding sequence) (Schaefer et al., 1997) . The other encoded the extracellular domain of the membrane-anchored NRG-1 isoform (NDF-a2c) (nucleotides 1 ± 900 of the coding sequence) (Wen et al., 1992) , which includes an 851 bp fragment (50 ± 900) that is identical to the C-terminal NRG-1 region of g-heregulin. The two biotinlabelled probes were hybridized in situ to metaphase chromosomes from two normal human males at ®nal concentrations of 15 and 20 ng/ml respectively. Fluorescence in situ hybridization (FISH) was performed as previously described (Callen et al., 1990) , except that chromosomes were stained prior to analysis with propidium iodide (as counter- Figure 3 A model of g-heregulin formation by chromosomal translocation. Domains of DOC-4 (11q13), NRG-1 isoform (NDF-b3) (8p12), and g-heregulin are shown and indicated, as in Figure 2 . The N-terminal region of g-heregulin up to the arrow is identical to that of DOC-4, and the C-terminal region of gheregulin after the arrow is the same as that of NRG-1. The last four residues (TTAI) of DOC-4 and the ®rst four residues (ALPP) of NDF-b3 are shown at the site (arrow) where the N-terminus of DOC-4 is joined to the C-terminus of NDF-b3 g-Heregulin is a fusion gene product X Liu et al stain) and DAPI (for chromosome identi®cation). Images of metaphase chromosome preparations were captured using a cooled CCD camera using the Chromoscan image collection and enhancement system (Applied Imaging Int. Ltd). FISH signals and the DAPI banding patterns were merged for ®gure preparation.
Dual colour FISH to MDA-MB-175 cells
Chromosome painting: commercially prepared whole chromosome paints for chromosome 8 (Boehringer, DIGlabelled) and chromosome 11 (Cambio, biotin-labelled) were co-hybridized to metaphase chromosomes from MDA-MB-175 cells according to manufacture's instructions and detected with TRITC (for chromosome 8) and FITC (for chromosome 11).
Centromere plus chromosome painting: a commercially prepared probe for the centromeric alphoid repeat region of chromosome 11 (D11Z1, Oncor, biotin-labelled) and a chromosome 8 paint (as above) were co-hybridized to the cells.
Primed in situ labelling (PRINS)
This was performed essentially as described by Pellestor et al. (1994) . Metaphase preparations from MDA-MB-175 cells were spread onto a methanol-cleaned glass slide and kept overnight at room temperature. A reaction mix containing 100 pmoles of the primer (5'-CTA TCA ATA GAA ATG TTC AGC ACA GTT-3'), 0.2 mM each of dATP, dCTP, and dGTP, 0.02 mM dTTP (Boehringer), 0.02 mM¯uorescein-12-dUTP (Boehringer), 50 mM KCl, 10 mM Tris-HCl pH 8.3, 1.5 mM MgCl 2 , 0.01% bovine serum albumin, and 2.5 U of Taq DNA polymerase (Gibco BRL) was applied to the slide and sealed with a coverslip and rubber cement. A denaturation (938C, 3 min), annealing (608C, 10 min), and extension (728C, 15 min) program was performed on the¯at block of a Hybaid PCR Express apparatus.
